Literature DB >> 23740097

Extension MRI is clinically useful in cervical myelopathy.

R J V Bartlett1, A S Rigby, J Joseph, A Raman, A Kunnacherry, C A Rowland Hill.   

Abstract

INTRODUCTION: Cervical spine MRI with the neck in extension has been well described over the last 10 years, but its clinical value remains unknown.
METHODS: We performed extension imaging in 60 patients in whom the initial neutral study showed borderline cord compression. Images were assessed using a previously validated grading system for cord compression. Multiple linear and area measurements were also obtained. Images were scored blindly and randomly. Inter- and intra-rater variability were determined in a subset of 20 cases. Independent clinical assessment utilised the Ranwat criteria.
RESULTS: For most parameters inter/intra-observer variance of kappa/ICC > 0.6 was highly satisfactory. Standard MR was poor at discriminating between patients with and without myelopathy (ROC analysis, area under the curve (AUC), 0.52). This was considerably improved with extension imaging (AUC, 0.60), or by using the change in compression score between neutral and extension studies. Most measurements were not helpful; however, the ratio of cord area/CSF area at the level of maximum compression on extended images was the best discriminator (AUC, 0.71), as well as the presence of T2 change in cord substance (AUC, 0.68).
CONCLUSION: This is the first study to demonstrate added clinical value utilising extension MRI. In this cohort of difficult patients, when there was no T2 signal change in the cord, the presence of clinical myelopathy could only be predicted by utilising the data from extension imaging.

Entities:  

Mesh:

Year:  2013        PMID: 23740097     DOI: 10.1007/s00234-013-1208-z

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  21 in total

1.  Qualitative assessment of cervical spinal stenosis: observer variability on CT and MR images.

Authors:  Jeffrey S Stafira; Jagadeesh R Sonnad; William T C Yuh; David R Huard; Robin E Acker; Dan L Nguyen; Joan E Maley; Faridali G Ramji; Wen-Bin Li; Christopher M Loftus
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

2.  Dynamic changes of the spinal canal in patients with cervical spondylosis at flexion and extension using magnetic resonance imaging.

Authors:  C Muhle; D Weinert; A Falliner; J Wiskirchen; J Metzner; M Baumer; G Brinkmann; M Heller
Journal:  Invest Radiol       Date:  1998-08       Impact factor: 6.016

3.  The role of DTI in early detection of cervical spondylotic myelopathy: a preliminary study with 3-T MRI.

Authors:  Batuhan Kara; Azim Celik; Selhan Karadereler; Levent Ulusoy; Kursat Ganiyusufoglu; Levent Onat; Ayhan Mutlu; Ibrahim Ornek; Mustafa Sirvanci; Azmi Hamzaoglu
Journal:  Neuroradiology       Date:  2011-02-23       Impact factor: 2.804

4.  Statistical approaches to the analysis of receiver operating characteristic (ROC) curves.

Authors:  B J McNeil; J A Hanley
Journal:  Med Decis Making       Date:  1984       Impact factor: 2.583

5.  Dynamic magnetic resonance imaging of the cervical spine with high-resolution 3-dimensional T2-imaging.

Authors:  L Gerigk; T Bostel; A Hegewald; C Thomé; J Scharf; C Groden; E Neumaier-Probst
Journal:  Clin Neuroradiol       Date:  2011-12-23       Impact factor: 3.649

6.  A correlation between magnetic resonance imaging and electrophysiological findings in cervical spondylotic myelopathy.

Authors:  T Kanchiku; T Taguchi; K Kaneko; Y Fuchigami; H Yonemura; S Kawai
Journal:  Spine (Phila Pa 1976)       Date:  2001-07-01       Impact factor: 3.468

7.  Interobserver agreement on MRI evaluation of patients with cervical radiculopathy.

Authors:  B Kuijper; A Beelen; B F van der Kallen; F Nollet; G J Lycklama A Nijeholt; M de Visser; J Th J Tans
Journal:  Clin Radiol       Date:  2011-01       Impact factor: 2.350

8.  Cervical spine fusion in rheumatoid arthritis.

Authors:  C S Ranawat; P O'Leary; P Pellicci; P Tsairis; P Marchisello; L Dorr
Journal:  J Bone Joint Surg Am       Date:  1979-10       Impact factor: 5.284

9.  Cervical radiculopathy: prospective evaluation with surface coil MR imaging, CT with metrizamide, and metrizamide myelography.

Authors:  M T Modic; T J Masaryk; G P Mulopulos; C Bundschuh; J S Han; H Bohlman
Journal:  Radiology       Date:  1986-12       Impact factor: 11.105

10.  The relationship between the cervical spinal canal diameter and the pathological changes in the cervical spine.

Authors:  Yuichiro Morishita; Masatoshi Naito; Henry Hymanson; Masashi Miyazaki; Guizhong Wu; Jeffrey C Wang
Journal:  Eur Spine J       Date:  2009-04-09       Impact factor: 3.134

View more
  4 in total

1.  Kinetic DTI of the cervical spine: diffusivity changes in healthy subjects.

Authors:  Félix P Kuhn; Antoine Feydy; Nathalie Launay; Marie-Martine Lefevre-Colau; Serge Poiraudeau; Sébastien Laporte; Marc A Maier; Pavel Lindberg
Journal:  Neuroradiology       Date:  2016-06-08       Impact factor: 2.804

2.  Characterizing the location of spinal and vertebral levels in the human cervical spinal cord.

Authors:  D W Cadotte; A Cadotte; J Cohen-Adad; D Fleet; M Livne; J R Wilson; D Mikulis; N Nugaeva; M G Fehlings
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-18       Impact factor: 3.825

3.  The value of dynamic MRI in the treatment of cervical spondylotic myelopathy: a protocol for a prospective randomized clinical trial.

Authors:  Nanfang Xu; Youyu Zhang; Guangjin Zhou; Qiang Zhao; Shaobo Wang
Journal:  BMC Musculoskelet Disord       Date:  2020-02-07       Impact factor: 2.362

4.  Cord compression defined by MRI is the driving factor behind the decision to operate in Degenerative Cervical Myelopathy despite poor correlation with disease severity.

Authors:  Bryn Hilton; Jennifer Tempest-Mitchell; Benjamin M Davies; Jibin Francis; Richard J Mannion; Rikin Trivedi; Ivan Timofeev; John R Crawford; Douglas Hay; Rodney J Laing; Peter J Hutchinson; Mark R N Kotter
Journal:  PLoS One       Date:  2019-12-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.